191 related articles for article (PubMed ID: 30746903)
1. Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk.
Sinclair M; Hoermann R; Peterson A; Testro A; Angus PW; Hey P; Chapman B; Gow PJ
Liver Int; 2019 Jun; 39(6):1089-1097. PubMed ID: 30746903
[TBL] [Abstract][Full Text] [Related]
2. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis.
Sinclair M; Chapman B; Hoermann R; Angus PW; Testro A; Scodellaro T; Gow PJ
Liver Transpl; 2019 Oct; 25(10):1480-1487. PubMed ID: 31282126
[TBL] [Abstract][Full Text] [Related]
3. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis.
Eriksen CS; Kimer N; Suetta C; Møller S
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G729-G740. PubMed ID: 33729006
[TBL] [Abstract][Full Text] [Related]
4. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography.
Durand F; Buyse S; Francoz C; Laouénan C; Bruno O; Belghiti J; Moreau R; Vilgrain V; Valla D
J Hepatol; 2014 Jun; 60(6):1151-7. PubMed ID: 24607622
[TBL] [Abstract][Full Text] [Related]
6. Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients.
Hey P; Hoermann R; Gow P; Hanrahan TP; Testro AG; Apostolov R; Sinclair M
World J Transplant; 2022 Jun; 12(6):120-130. PubMed ID: 35979539
[TBL] [Abstract][Full Text] [Related]
7. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.
Tandon P; Ney M; Irwin I; Ma MM; Gramlich L; Bain VG; Esfandiari N; Baracos V; Montano-Loza AJ; Myers RP
Liver Transpl; 2012 Oct; 18(10):1209-16. PubMed ID: 22740290
[TBL] [Abstract][Full Text] [Related]
8. Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study.
van Vugt JLA; Buettner S; Alferink LJM; Bossche N; de Bruin RWF; Darwish Murad S; Polak WG; Metselaar HJ; IJzermans JNM
Transpl Int; 2018 Feb; 31(2):165-174. PubMed ID: 28871624
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry.
Giusto M; Lattanzi B; Albanese C; Galtieri A; Farcomeni A; Giannelli V; Lucidi C; Di Martino M; Catalano C; Merli M
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):328-34. PubMed ID: 25569567
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing Sarcopenia in Male Patients With Cirrhosis by Dual-Energy X-Ray Absorptiometry Estimates of Appendicular Skeletal Muscle Mass.
Belarmino G; Gonzalez MC; Sala P; Torrinhas RS; Andraus W; D'Albuquerque LAC; Pereira RMR; Caparbo VF; Ferrioli E; Pfrimer K; Damiani L; Heymsfield SB; Waitzberg DL
JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):24-36. PubMed ID: 28402708
[TBL] [Abstract][Full Text] [Related]
11. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
[TBL] [Abstract][Full Text] [Related]
12. Refining dual-energy x-ray absorptiometry data to predict mortality among cirrhotic outpatients: A retrospective study.
Santos LAA; Lima TB; Qi X; Paiva SAR; Romeiro FG
Nutrition; 2021 May; 85():111132. PubMed ID: 33545545
[TBL] [Abstract][Full Text] [Related]
13. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.
Montano-Loza AJ; Meza-Junco J; Baracos VE; Prado CM; Ma M; Meeberg G; Beaumont C; Tandon P; Esfandiari N; Sawyer MB; Kneteman N
Liver Transpl; 2014 Jun; 20(6):640-8. PubMed ID: 24678005
[TBL] [Abstract][Full Text] [Related]
14. Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease score.
Sinclair M; Gow PJ; Grossmann M; Shannon A; Hoermann R; Angus PW
Liver Transpl; 2016 Nov; 22(11):1482-1490. PubMed ID: 27542090
[TBL] [Abstract][Full Text] [Related]
15. Muscle wasting is associated with mortality in patients with cirrhosis.
Montano-Loza AJ; Meza-Junco J; Prado CM; Lieffers JR; Baracos VE; Bain VG; Sawyer MB
Clin Gastroenterol Hepatol; 2012 Feb; 10(2):166-73, 173.e1. PubMed ID: 21893129
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites.
Kim TY; Kim MY; Sohn JH; Kim SM; Ryu JA; Lim S; Kim Y
J Korean Med Sci; 2014 Sep; 29(9):1253-9. PubMed ID: 25246744
[TBL] [Abstract][Full Text] [Related]
17. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
[TBL] [Abstract][Full Text] [Related]
18. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation.
Degré D; Bourgeois N; Boon N; Le Moine O; Louis H; Donckier V; El Nakadi I; Closset J; Lingier P; Vereerstraeten P; Gelin M; Adler M
Transpl Int; 2004 Jan; 17(1):31-8. PubMed ID: 14745489
[TBL] [Abstract][Full Text] [Related]
19. Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication?
Stirnimann G; Ebadi M; Tandon P; Montano-Loza AJ
Curr Gastroenterol Rep; 2018 Sep; 20(11):50. PubMed ID: 30259203
[TBL] [Abstract][Full Text] [Related]
20. Use of Skeletal Muscle Index as a Predictor of Wait-List Mortality in Patients With End-Stage Liver Disease.
Kappus MR; Wegermann K; Bozdogan E; Patel YA; Janas G; Shropshire E; Parish A; Niedzwiecki D; Muir AJ; Bashir M
Liver Transpl; 2020 Sep; 26(9):1090-1099. PubMed ID: 32433802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
